Abstract:Background Choriocarcinoma is a highly aggressive, malignant trophoblastic neoplasm that can be gestational or non-gestational in origin. Accurate discrimination between these two subtypes, the causative pregnancy type, and the pregnancy-to-treatment interval for gestational choriocarcinoma are vital for clinical management. Methods Fifteen choriocarcinomas were genotyped using multiplex fluorescent polymerase chain reaction amplification of 15 short tandem repeat (STR) loci and the amelogenin locus (XY determination). Genotype patterns at each locus from tumoral and maternal tissues were compared, and any prior or concurrent mole/placenta was also compared when available. According to STR results showing the presence or absence of the paternal chromosomal complement, the gestational or non-gestational origin of the tumor and the nature of the causative pregnancy was identified. Results Fourteen tumors were gestational. Of these, seven were androgenetic/homozygous XX, and two were androgenetic/heterozygous XX, indicating that the causative pregnancies were molar pregnancies. Among the nine molar pregnancies, five were of the occult type. A menopausal patient developed a tumor from a mole that occurred seven years ago, identified by the genetically identical allele from the tumor and prior mole. One tumor originating from a previous mole was interrupted by term delivery. Two tumors found eight weeks postpartum were identified as originating from a prior occult mole. A pelvic choriocarcinoma was separated from a genetically distinct third trimester intrauterine placenta. Five gestational tumors were biparental: 2 XX, 3 XY. Of three ovarian tumors, two were confirmed gestational (1 androgenetic/homozygous XX; 1 biparental XY), and one was an ovarian tumor (XX) with a complete match of the genotype for all 15 loci, therefore ascertaining its non-gestational origin. Conclusion Gestational choriocarcinoma can originate in an androgenetic or biparental manner. The majority are androgenetic/homozygous XX, while a large number of them might be occult molar pregnancies. The origin of ectopic androgenetic choriocarcinoma with concurrent intrauterine placenta might be from either dispermic twin gestation (mole and coexistent nonmolar fetus) or an antecedent molar pregnancy. Choriocarcinoma shortly postpartum might not be associated with the last placenta. STR analysis can be useful in distinguishing gestational choriocarcinoma from non-gestational, as well as the causative pregnancy, and serve as a helpful examination tool for guiding clinical management.

Caspase Activity is Downregulated in Choriocarcinoma: a Cdna Array Differential Expression Study

Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.

[Expression of Caspase Apoptosis Pathway Genes Mrna in Colorectal Cancer and Polyps].

Down-regulation and Promoter Methylation of Tissue Inhibitor of Metalloproteinase 3 in Choriocarcinoma.

The expression of G1-S cell cycle inhibitors in normal placenta and gestational trophoblastic diseases

Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia: PSCA and trophoblastic neoplasia

Using Short Tandem Repeat Analysis for Choriocarcinoma Diagnosis: a Case Series

Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.

CTHRC1 Promotes Growth, Migration and Invasion of Trophoblasts Via Reciprocal Wnt/β-catenin Regulation

Declined placental PLAC1 expression is involved in preeclampsia.

Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

Analysis of PD-L1 Expression in Trophoblastic Tissues and Tumors.

Methylation Status and Expression of E-cadherin and Cadherin-11 in Gestational Trophoblastic Diseases

Abnormal Apoptosis Of Trophoblastic Cells Is Related To The Up- Regulation Of Cyp11a Gene In Placenta Of Preeclampsia Patients

Expression of Caspase-8 And-10 in Colorectal Cancer and Its Association with Tumor Cell Apoptosis

Differential gene expression identified in complete hydatidiform mole by combining suppression subtractive hybridization and cDNA microarray.

Reduced Syncytin-1 Expression in Choriocarcinoma BeWo Cells Activates the Calpain1–aif-Mediated Apoptosis, Implication for Preeclampsia

p21(WAF1/CIP1) expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression

P21waf1/cip1 Expression in Gestational Trophoblastic Disease: Correlation with Clinicopathological Parameters, and Ki67 and P53 Gene Expression.

Expression of TGF-beta Signaling Proteins in Normal Placenta and Gestational Trophoblastic Disease.